Sunshine Biopharma (SBFM) Interest Coverage Ratio (2012 - 2026)
Sunshine Biopharma's (SBFM) quarterly Interest Coverage Ratio came in at 7.73 in Q1 2026, down 10.17% YoY from 8.6 in Q1 2025, and down 35.66% on a QoQ basis from 5.7 in Q3 2025.
Sunshine Biopharma (SBFM) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 14 years of Interest Coverage Ratio data on file, last reported at 7.73 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 10.17% year-over-year to 7.73 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 35.03 (down 13.37% YoY) and the FY2025 annual result came in at 0.74, up 11.62% from the prior year.
- Interest Coverage Ratio eased to 7.73 in Q1 2026, from 5.7 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1816.2 in Q4 2022 to a low of 858990.0 in Q3 2022.
- A 5-year average of 57176.85 and a median of 10.65 in 2024 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 75868.02% in 2022, down 8109137.82% in 2022.
- Tracing SBFM's Interest Coverage Ratio over 5 years: stood at 1816.2 in 2022, then slumped by 102.17% to 39.43 in 2023, then plunged by 555.76% to 258.56 in 2024, then soared by 97.8% to 5.7 in 2025, then slumped by 35.66% to 7.73 in 2026.
- The last three Interest Coverage Ratio figures came in at 7.73 (Q1 2026), 5.7 (Q3 2025), and 10.55 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.10 |
| Mar 31, 2026 | -7.73 |
| Sep 30, 2025 | -5.70 |
| Jun 30, 2025 | -10.55 |
| Mar 31, 2025 | -7.01 |
| Dec 31, 2024 | -258.56 |
| Sep 30, 2024 | -10.65 |
| Jun 30, 2024 | -12.38 |
| Mar 31, 2024 | -13.05 |
| Dec 31, 2023 | -39.43 |
| Sep 30, 2023 | -7.08 |
| Jun 30, 2023 | -9.02 |
| Mar 31, 2023 | -17.65 |
| Dec 31, 2022 | 1,816.20 |
| Sep 30, 2022 | -858,990.00 |
| Mar 31, 2022 | -80.11 |
| Dec 31, 2021 | 2.39 |
| Sep 30, 2021 | -10.59 |
| Jun 30, 2021 | -1.99 |
| Mar 31, 2021 | -25.66 |